This inventor holds 8 USPTO granted patents. Top assignees: Ube Industries, Inc., Sankyo Company, Limited, Daiichi Sankyo Company, Limited. Active years: 1981-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 1981-2010
Title: The Innovative Contributions of Takashi Kobayashi
Introduction
Takashi Kobayashi is a notable inventor based in Ube, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating various medical conditions. With a total of 8 patents to his name, Kobayashi's work has had a meaningful impact on the industry.
Latest Patents
Among his latest patents, one includes an optically active dihydropyridine derivative. This compound, specifically (R)-2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-(1-diphenylmethylazetidin-3-yl) ester 5-isopropyl ester, is designed for use in treating circulatory diseases. Another significant patent involves cyclopenta[d]pyrimidine derivatives, which have demonstrated valuable antidepressant activity. These compounds may be utilized in the treatment of mental depression, showcasing Kobayashi's commitment to addressing critical health issues.
Career Highlights
Throughout his career, Takashi Kobayashi has worked with prominent companies such as Ube Industries, Inc. and Sankyo Company Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in the pharmaceutical sector.
Collaborations
Kobayashi has collaborated with esteemed colleagues, including Takeo Honda and Katsutoshi Fujii. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in the field of medicine.
Conclusion
Takashi Kobayashi's innovative work and dedication to pharmaceutical research have led to significant advancements in treatments for circulatory diseases and mental health. His contributions continue to influence the industry and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile